SP is not a career move one should make - Avis employé Director Merck

2,0
18 sept. 2008
Recommande
Approbation du PDG
Perspective commerciale

Avantages

its in NJ. if you are based in NJ, it's an option.

Inconvénients

poor decisions have hurt the reputation of the company- both prior to Hassan joining and initiating the 'turnaround', and after the 'turnaround'. The turnaround was successful, and placed an emphasis on ethical behavior- yet recent alleged events in Senior Mgmt undermined this mission. I have never seen such bad luck, combined with lack of decision-making or poor decisions, affect a company so lastingly. Morale is low, job cuts are occurring, I would be surprised if the company is still around in 5 years.

Découvrez plus d’avis sur Merck

5,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Excellent company to work with.

Inconvénients

No cons encountered so far

4,0
30 juin 2026
Recommande
Approbation du PDG
Perspective commerciale

Avantages

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Inconvénients

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Voir les avis par: Utile|Évaluation|Date|Tout